• Join
  • Login
  • Contact

Search abstracts / presentations

Cost-effectiveness analysis of pharmaceutical care in hypertension and diabetes in Poland – a Markov model

  • In: D5 - Pharmacy Practice Research: Assessing the evidence and research needs of integrated care for complex patients on Thursday, 5 September 2013, 14:00-17:00
  • At: Dublin (Ireland) (2013)
  • Type: Presentations + Posters
  • By: SKOWRON, Agnieszka (Jagiellonian University Medical College, Department of Social Pharmacy, Krakow, Poland)
  • Co-author(s): Polak, Wioletta (Jagiellonian University Medical College, Krakow, Poland)
  • Abstract:


    Pharmaceutical care (PC) is not reimbursed in Poland. Polish law enables reimbursement of new service only if it is cost effective.


    To compare costs and effectiveness of PC and standard medical care (SMC) for hypertensive (HT) and/or diabetic (DM) patients.

    community pharmacies and GP offices.

    Markov models were


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses